OCGN

News Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit

7d ago

News Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

14d ago

News Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why

14d ago

Short volume Short volume 83% of volume (4.4σ)

27d ago

News Ocugen outlines plan for 3 BLAs by 2028 as it expects cash runway into 2028

28d ago

News Ocugen stock dips as Q1 losses widen

28d ago

SEC filing OCGN Reports $112.1M Cash, $115M 6.75% Convertible Notes, Phase 3 GA Trial Shows 31% Lesion Reduction, 20% No Progression, 75% >30% Iesion Shrinkage, BLA Targets 2027, Cash Runway to 2028

28d ago

SEC filing OCGN Announces 31% Lesion Growth Reduction in Phase 2 GA Trial, 55% ≥30% Shrinkage, No SAEs, Phase 3 Ready

70d ago

SEC filing OCGN Raises $15M via 10M Share Warrant Exercise, Extends Cash Runway to Q1 2027

74d ago

News Ocugen a new buy at Canaccord on pipeline for retinal diseases

76d ago

News Ocugen spikes as Oppenheimer issues new Outperform on upcoming catalysts

83d ago

Scanner Unusual buy pressure (8.2x avg, 78% up-volume, +18.4% / +0.34 intraday, above VWAP)

83d ago

SEC filing OCGN Proposes 95M Share Increase, Series C Preferred Stock 1,000 Votes/Share, Redeems Unvoted Shares

90d ago

SEC filing OCGN Reports $100M Revenue, $0.05 EPS, Advances OCU400 Phase 3 Data 2027, OCU410ST Phase 2/3 2026, $500M Licensing Deal

90d ago

News Earnings week ahead: AVGO, CRWD, PLUG, COST, TGT, MRVL, JD, KR, and more

93d ago

News Ocugen prices $22.5M common stock offering at $1.50 per share

132d ago

News Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock

132d ago

News Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

140d ago

News UPDATE - Vocodia Announces Commitment Letter to Acquire a Majority of Privacy Pal LLC; Tech Industry Veteran Jason Melo to Serve as CEO

146d ago